Sending Office: Honorable Bonnie Watson Coleman
COSPONSOR H.R. 1643 – THE PrEP ASSISTANCE PROGRAM ACT
Supported by: amfAR (The Foundation for AIDS Research), AIDS United, National Alliance of State & Territorial AIDS Directors
Cosponsors (18): Maloney (NY-18), Clarke, Norton, Nadler, Wasserman Schultz, Jackson Lee, Scott (GA-13), Hastings, Brown, Roybal-Allard, Engel, Serrano, Rush, Cohen, Johnson, Jr. (GA-4), Pocan, Moore, Schiff
I invite you to cosponsor
H.R. 1643 – The PrEP Assistance Program Act which will help in the fight to eradicate the spread of HIV.
The PrEP Assistance Program Act would direct the Department of Health and Human Services to create a grant program that would fund existing PrEP Assistance Programs or create new ones in a state, territory, or Indian tribe. The grants that would be awarded
will help cover the costs of PrEP medication, clinic and laboratory fees, sexually transmitted disease testing, treatment adherence counseling, and outreach and awareness toward high-risk populations to increase awareness about the existence of PrEP. The legislation
also directs the Secretary to report to Congress and make available to the public the impact of the grant programs to help provide useful feedback on progress.
For individuals who are HIV negative but particularly vulnerable to contracting the virus, pre exposure prophylaxis or PrEP, can be an important medical tool to greatly lower the risk of becoming HIV positive. Despite PrEP medications being available for
more than five years, it is still not well known by the vast majority of Americans, especially in communities where the HIV rate is higher than average. Among the more than 1.1 million Americans living with HIV, the disparity in prevalence among different
communities is alarming. African Americans represent 12% of the US population but account for 44% of HIV diagnoses, for Latinos that is 25% even though they represent 18% of the US population. With the PrEP Assistance Program Act, we can help reduce the spread
of HIV, especially among communities most impacted, and come closer to the day of eradicating this horrific disease.
For more information on the legislation or if you would like to be included as a cosponsor, please contact Brad Korten (email@example.com) or call (202) 225-5801. Thank you for your consideration.
BONNIE WATSON COLEMAN
Member of Congress
e-Dear Colleague version 2.0